Krebs Biochemicals & Industries Ltd

Know More
NSEBSE

78.700.65 (0.83%)

03:40 PM,6th Dec 2023

79.061.05 (1.35%)

04:01 PM,6th Dec 2023

BSE : 524518

NSE : KREBSBIO

Sector : Health care

ISIN Code : INE268B01013

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 06 2023 | 04:01 PM IST

Market Cap (₹ Cr)

169

Turnover (₹ Cr)

0.01

Volume (Shares)

17587

Face Value

10

52-WK High

120.25

52-WK High Date

09 Dec 2022

52-WK Low

50.65

52-WK Low Date

29 Mar 2023

All Time High

284.00

All Time High Date

04 Jun 1998

All Time Low

46.58

All Time Low Date

29 Jan 1996

Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd) promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process one among very few in the world to do the same.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. KBIL since inception has adopted global agenda for its growth by focusing on its specific area of expetise 'Fermentation Technology'. During 2001-02 the company has successfully launched Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing LovastatinSimvastatin and Vitamin-C. The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28 2003.

Krebs Biochemicals & Industries Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

169

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

-1.57

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]-50.26
P/B Ratio (₹) [S]-1.57
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

78.00

79.65

Week Low/High

77.05

83.00

Month Low/High

77.05

94.00

Year Low/High

50.65

120.00

All time Low/High

9.10

284.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.14%-3.79%4.114.19%
1 Month-9.71%-10.01%7.237.86%
3 Month21.92%22.30%5.736.76%
6 Month23.01%21.45%10.9312.57%
1 Year-30.42%-29.70%11.2212.31%
3 Year-20.10%-20.98%54.5157.92%

Company Info

Company Information

Independent Director : G V L Prasad

Chairman (Non-Executive) : R T Ravi

Director : Avinash Ravi

Independent Director : Tangirala Malati

Independent Director : Satish Khivsara

Independent Director : Raj Kamal Prasad Verma

Managing Director : Pabitra Bhattacharya

Director : Jitendra Shah

Company Sec. & Compli. Officer : Rohit Taparia

Registered Office: Kothapalli(V) Kasimkota(M), Anakapalli,Vishakapatnam,Andhra Pradesh-531031 Ph: 91-040-6680 8040

Email:investors@kerbsbiochem.com

URL:http://www.krebsbiochem.com